vs
PETMED EXPRESS INC（PETS）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是PETMED EXPRESS INC的1.7倍（$69.8M vs $40.7M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -26.0%，领先410.0%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -23.3%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -20.9%）
PetMed Express，也叫PetMeds，是总部位于美国的线上宠物药房。该企业公开上市，主营宠物处方及非处方药物销售业务，是北美知名的宠物医药线上零售平台。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
PETS vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.7倍
$40.7M
营收增速更快
RIGL
高出44.5%
-23.3%
净利率更高
RIGL
高出410.0%
-26.0%
两年增速更快
RIGL
近两年复合增速
-20.9%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $40.7M | $69.8M |
| 净利润 | $-10.6M | $268.1M |
| 毛利率 | 23.3% | 91.5% |
| 营业利润率 | -25.7% | 33.2% |
| 净利率 | -26.0% | 384.0% |
| 营收同比 | -23.3% | 21.2% |
| 净利润同比 | -1392.6% | 1769.2% |
| 每股收益（稀释后） | $-0.50 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PETSRIGL
| Q4 25 | $40.7M | $69.8M | ||
| Q3 25 | $44.4M | $69.5M | ||
| Q2 25 | $51.2M | $101.7M | ||
| Q1 25 | $50.8M | $53.3M | ||
| Q4 24 | $52.0M | $57.6M | ||
| Q3 24 | $58.0M | $55.3M | ||
| Q2 24 | $66.2M | $36.8M | ||
| Q1 24 | $65.1M | $29.5M |
净利润PETSRIGL
| Q4 25 | $-10.6M | $268.1M | ||
| Q3 25 | $-8.5M | $27.9M | ||
| Q2 25 | $-34.2M | $59.6M | ||
| Q1 25 | $-11.6M | $11.4M | ||
| Q4 24 | $-707.0K | $14.3M | ||
| Q3 24 | $2.3M | $12.4M | ||
| Q2 24 | $3.8M | $-1.0M | ||
| Q1 24 | $-5.0M | $-8.2M |
毛利率PETSRIGL
| Q4 25 | 23.3% | 91.5% | ||
| Q3 25 | 28.0% | 93.2% | ||
| Q2 25 | 28.1% | 95.6% | ||
| Q1 25 | 29.9% | 91.7% | ||
| Q4 24 | 31.0% | 89.9% | ||
| Q3 24 | 32.3% | 85.5% | ||
| Q2 24 | 28.8% | 92.4% | ||
| Q1 24 | 29.3% | 93.1% |
营业利润率PETSRIGL
| Q4 25 | -25.7% | 33.2% | ||
| Q3 25 | -18.9% | 40.9% | ||
| Q2 25 | -66.7% | 60.1% | ||
| Q1 25 | -11.9% | 23.9% | ||
| Q4 24 | -0.9% | 28.9% | ||
| Q3 24 | 1.0% | 25.4% | ||
| Q2 24 | 6.6% | 1.2% | ||
| Q1 24 | -5.9% | -23.6% |
净利率PETSRIGL
| Q4 25 | -26.0% | 384.0% | ||
| Q3 25 | -19.2% | 40.2% | ||
| Q2 25 | -66.7% | 58.6% | ||
| Q1 25 | -22.9% | 21.5% | ||
| Q4 24 | -1.4% | 24.9% | ||
| Q3 24 | 4.0% | 22.5% | ||
| Q2 24 | 5.7% | -2.8% | ||
| Q1 24 | -7.7% | -27.9% |
每股收益（稀释后）PETSRIGL
| Q4 25 | $-0.50 | $14.11 | ||
| Q3 25 | $-0.41 | $1.46 | ||
| Q2 25 | $-1.65 | $3.28 | ||
| Q1 25 | $-0.56 | $0.63 | ||
| Q4 24 | $-0.03 | $0.82 | ||
| Q3 24 | $0.11 | $0.70 | ||
| Q2 24 | $0.18 | $-0.06 | ||
| Q1 24 | $-0.24 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $26.9M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $32.8M | $391.5M |
| 总资产 | $88.0M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资PETSRIGL
| Q4 25 | $26.9M | $155.0M | ||
| Q3 25 | $36.1M | $137.1M | ||
| Q2 25 | $41.1M | $108.4M | ||
| Q1 25 | $54.7M | $77.1M | ||
| Q4 24 | $50.1M | $77.3M | ||
| Q3 24 | $52.0M | $61.1M | ||
| Q2 24 | $46.0M | $49.1M | ||
| Q1 24 | $55.3M | $49.5M |
总债务PETSRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益PETSRIGL
| Q4 25 | $32.8M | $391.5M | ||
| Q3 25 | $43.1M | $117.6M | ||
| Q2 25 | $51.5M | $81.9M | ||
| Q1 25 | $85.1M | $18.6M | ||
| Q4 24 | $96.2M | $3.3M | ||
| Q3 24 | $96.4M | $-14.6M | ||
| Q2 24 | $93.5M | $-29.9M | ||
| Q1 24 | $96.7M | $-31.7M |
总资产PETSRIGL
| Q4 25 | $88.0M | $513.6M | ||
| Q3 25 | $100.3M | $242.5M | ||
| Q2 25 | $109.8M | $206.7M | ||
| Q1 25 | $148.7M | $176.0M | ||
| Q4 24 | $144.8M | $164.0M | ||
| Q3 24 | $146.0M | $139.4M | ||
| Q2 24 | $152.7M | $128.4M | ||
| Q1 24 | $169.9M | $126.5M |
负债/权益比PETSRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-9.2M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-9.2M | — |
| 自由现金流率自由现金流/营收 | -22.7% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-23.0M | — |
8季度趋势，按日历期对齐
经营现金流PETSRIGL
| Q4 25 | $-9.2M | $22.0M | ||
| Q3 25 | $-2.2M | $24.0M | ||
| Q2 25 | $-12.3M | $30.5M | ||
| Q1 25 | $7.0M | $-893.0K | ||
| Q4 24 | $-1.2M | $14.5M | ||
| Q3 24 | $7.4M | $21.7M | ||
| Q2 24 | $-8.5M | $302.0K | ||
| Q1 24 | $7.1M | $-5.0M |
自由现金流PETSRIGL
| Q4 25 | $-9.2M | — | ||
| Q3 25 | $-4.8M | — | ||
| Q2 25 | $-13.6M | — | ||
| Q1 25 | $4.6M | — | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $6.1M | — | ||
| Q2 24 | $-9.2M | — | ||
| Q1 24 | $5.9M | — |
自由现金流率PETSRIGL
| Q4 25 | -22.7% | — | ||
| Q3 25 | -10.8% | — | ||
| Q2 25 | -26.5% | — | ||
| Q1 25 | 9.1% | — | ||
| Q4 24 | -3.7% | — | ||
| Q3 24 | 10.6% | — | ||
| Q2 24 | -13.9% | — | ||
| Q1 24 | 9.0% | — |
资本支出强度PETSRIGL
| Q4 25 | 0.1% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 1.5% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 1.9% | — |
现金转化率PETSRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 3.18× | 1.75× | ||
| Q2 24 | -2.27× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PETS
| Reorder | $34.0M | 84% |
| New Order | $5.0M | 12% |
| Membership Fees | $1.6M | 4% |
RIGL
暂无分部数据
